Lv1
20 积分 2025-02-10 加入
Spectrum of Primary Aldosteronism and Risk of Cardiovascular Outcomes
2天前
求助中
The ARIC (Atherosclerosis Risk In Communities) Study
14天前
已完结
Spectrum of Primary Aldosteronism and Risk of Cardiovascular Outcomes
22天前
已完结
Comparative effects of different antiplatelet strategies in carriers of CYP2C19 loss-of-function alleles: a network meta-analysis
1个月前
已完结
Rationale and design of the effect of evolocumab in patients at high cardiovascular risk without prior myocardial infarction or stroke (VESALIUS-CV) trial
1个月前
已完结
Evolocumab in Patients without a Previous Myocardial Infarction or Stroke
1个月前
已完结
Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes
1个月前
已完结
Combining Genomics With Lipid and Inflammatory Biomarkers to Predict Coronary Artery Disease Risk
1个月前
已完结
Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR
1个月前
已完结
Ticagrelor versus Clopidogrel in CYP2C19 Loss-of-Function Carriers with Stroke or TIA
1个月前
已完结
皖公网安备34019202002308
